Form 8-K - Current report:
SEC Accession No. 0001759425-25-000034
Filing Date
2025-05-30
Accepted
2025-05-30 16:35:29
Documents
12
Period of Report
2025-05-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mirm-20250529.htm   iXBRL 8-K 36957
  Complete submission text file 0001759425-25-000034.txt   152304

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20250529.xsd EX-101.SCH 1782
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20250529_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20250529_pre.xml EX-101.PRE 12508
14 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20250529_htm.xml XML 2876
Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 251011595
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)